Rahul S. Dalal
Appearances
DateMay 9, 2023BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…Presenter
Speakers
- DateMay 18, 2024Background: We compared real-world outcomes of upadacitinib (upa) vs tofacitinib (tofa) for ulcerative colitis (UC) through 52 weeks…
Presenter
Speakers
University of North Carolina School of MedicineBrigham and Women's Hospital - DateMay 18, 2024
Presenters
Icahn School of Medicine Mount Sinai Hospital 
DateMay 18, 2024Speakers
Icahn School of Medicine Mount Sinai Hospital
DateMay 18, 2024MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIESModerators
Vanderbilt University Medical CenterMayo Foundation for Medical Education and Research
